Anqi Li

6PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
Combined inhibition of BETs and HDACs as a potential epigenetics-based therapy for malignant rhabdoid tumor.

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

|Feb 04, 2025
Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in gastric adenosquamous carcinoma.

Yijin Gu, Zebing Liu, Xia Sheng

|Jun 19, 2020
Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes.

Fresia Pareja, Arnaud Da Cruz Paula, Rodrigo Gularte-Mérida

|Nov 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers.

Anqi Li, Felipe C Geyer, Pedro Blecua

|Aug 21, 2019
Homologous recombination DNA repair defects in PALB2-associated breast cancers.

Anqi Li, Felipe C Geyer, Pedro Blecua

Pageof 1

Frequent Collaborators

3 joint publications

Rodrigo Gularte-Mérida

2 joint publications

Rahul Kumar

2 joint publications

Barbara Rivera

2 joint publications

Salvatore Piscuoglio